Despite the significant need for coordinated approaches to the treatment of substance misuse worldwide, there are still major gaps in both the provision of services and in the development of a theoretically unified approach to care. We suggest that a phenomenological approach to care can provide comprehensive, theoretically grounded guidelines that coordinate and help choose between a range of interventions while respecting the values of the patient and other stakeholders. The aim of this paper is to present a framework for a person-centered approach to substance misuse care, based on general principles of phenomenology. In particular, we emphasize a dialectic conception of phenomenological care, one that considers the various tensions and conflicts of human life, and the ways these are managed by individuals. Two dialectics are presented here: the dialectic of anthropological proportions, involved in the existential situation of the substance misuser, and the dialect of decision, which is essential to all approaches to the treatment of substance misuse. The dialectic of proportions in the substance misuser’s experience involves hyperpresentification, the tendency to emphasize the present moment to the relative exclusion or reduction of the past and future considerations, and feelings of plenitude, an oversimplification of experience that ignores the complexity present in every situation. Interventions should reflect a dialectic of decision, which allows the clinician and patient to choose pathways that promote movement and expand the limitations of hyperpresentification and plenitude. This phenomenological framework, we suggest, permits a collaborative and values-based approach to comprehensive clinical decision-making.

1.
APA [American Psychiatric Association]: Diagnostic and Statistical Manual of Mental Disorders, ed 5th. Arlington, VA, American Psychiatric Publishing,
2013
.
2.
WHO
.
International statistical classification of diseases and related health problems
. 10th revision, ed 10th.
Geneva
:
World Health Organization
;
1999
.[
World Health Organization
].
3.
Whiteford
HA
,
Degenhardt
L
,
Rehm
J
,
Baxter
AJ
,
Ferrari
AJ
,
Erskine
HE
, et al
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010
.
Lancet
.
2013
Nov
;
382
(
9904
):
1575
86
.
[PubMed]
0140-6736
4.
UNDOC [United Nations Office on Drugs and Crime]: Manual for the Training of Policymakers on the Nature, Prevention and Treatment of Drug Use Disorders. Vienna, United Nations,
2016
.
5.
Carroll
KM
:
Methodological issues and problems in the assessment of substance use.
1995
;7:349-358.
6.
Dean
A
.
Complexity and Substance Misuse
.
Addict Res Theory
.
2001
;
9
(
1
):
19
41
. 1606-6359
7.
Marsh Dr
A
,
Dale
A
.
Risk factors for alcohol and other drug disorders: A review
.
Aust Psychol
.
2005
;
40
(
2
):
73
80
. 0005-0067
8.
Belcher
AM
,
Volkow
ND
,
Moeller
FG
,
Ferré
S
.
Personality traits and vulnerability or resilience to substance use disorders
.
Trends Cogn Sci
.
2014
Apr
;
18
(
4
):
211
7
.
[PubMed]
1364-6613
9.
Shelby
CL
.
Addiction: A Philosophical Perspective
.
UK
:
Palgrave Macmillan
;
2016
.
10.
Hall
W
,
Carter
A
,
Forlini
C
.
The brain disease model of addiction: is it supported by the evidence and has it delivered on its promises?
Lancet Psychiatry
.
2015
Jan
;
2
(
1
):
105
10
.
[PubMed]
2215-0366
11.
Arria
AM
,
McLellan
AT
.
Evolution of concept, but not action, in addiction treatment
.
Subst Use Misuse
.
2012
Jun-Jul
;
47
(
8-9
):
1041
8
.
[PubMed]
1082-6084
12.
Leichsenring
F
,
Steinert
C
.
Is Cognitive Behavioral Therapy the Gold Standard for Psychotherapy?: The Need for Plurality in Treatment and Research
.
JAMA
.
2017
Oct
;
318
(
14
):
1323
4
.
[PubMed]
0098-7484
13.
Potenza
MN
,
Sofuoglu
M
,
Carroll
KM
,
Rounsaville
BJ
.
Neuroscience of behavioral and pharmacological treatments for addictions
.
Neuron
.
2011
Feb
;
69
(
4
):
695
712
.
[PubMed]
0896-6273
14.
Bradley
KA
,
Kivlahan
DR
.
Bringing patient-centered care to patients with alcohol use disorders
.
JAMA
.
2014
May
;
311
(
18
):
1861
2
.
[PubMed]
0098-7484
15.
Kolind
T
,
Hesse
M
.
Patient-centred care-perhaps the future of substance abuse treatment
.
Addiction
.
2017
Mar
;
112
(
3
):
465
6
.
[PubMed]
0965-2140
16.
Mezzich
JE
,
Salloum
IM
,
Cloninger
CR
,
Salvador-Carulla
L
,
Kirmayer
LJ
,
Banzato
CE
, et al
Person-centred integrative diagnosis: conceptual bases and structural model
.
Can J Psychiatry
.
2010
Nov
;
55
(
11
):
701
8
.
[PubMed]
0706-7437
17.
Sass
L
. Phenomenology as Description and as Explanation: The Case of Schizophrenia. In:
Schmicking
D
,
Gallagher
S
, editors
.
Handbook of Phenomenology and Cognitive Science
.
Dordrecht
:
Springer
;
2010
.
18.
Messas
G
,
Zorzanelli
R
,
Tamelini
M
. The Life-World of Hysteria; in Stanghellini G, Broome M, Raballo A, Fernandez A, P F-P, Rosfort R (eds): The Oxford Handbook of Phenomenological Psychopathology. Oxford, Oxford University Press,
2018
b.
19.
Messas
G
,
Tamelini
M
,
Mancini
M
,
Stanghellini
G
.
New Perspectives in Phenomenological Psychopathology: Its Use in Psychiatric Treatment
.
Front Psychiatry
.
2018
a
Sep
;
9
:
466
.
[PubMed]
1664-0640
20.
Dörr
O
.
Sobre la temporalidad de las adicciones; Psiquiatria antropológica: contribuiciones a uma psiquiatria de orientacion fenomenológica-antropologica
.
Santiago de Chile, Editorial Universitária
;
1997
.
21.
Kemp
R
.
The worlding of addiction
.
Humanist Psychol
.
2011
;
39
(
4
):
338
47
. 0887-3267
22.
Messas
GP
.
On the Essence of Drunkenness and the Pathway to Addiction: A Phenomenological Contribution
.
J Addict Behav Ther Rehabil
.
2014
a;
03
(
02
):
3
. 2324-9005
23.
Di Petta
G
.
Psychopathlogy of Addictions Journal of Psychopathology
.
2014
;
20
:
471
9
.
24.
Tamelini
M
,
Messas
G
.
Pharmacological treatment of schizophrenia in light of phenomenology
.
Philos Psychiatry Psychol
.
2019
;
26
(
2
):
133
42
. 1071-6076
25.
Stanghellini
G
. Phenomenological Psychopathology and Psychotherapy. In:
Stanghellini
G
,
Broome
M
,
Raballo
A
,
Fernandez
AV
,
Fusar-Poli
P
,
Rosfort
R
, editors
.
The Oxford Handbook of Phenomenological Psychopathology Oxford University Press
.
2018
.
26.
Messas
GP
,
Tamelini
MG
.
The Pragmatic Value of Notions of Dialectics and Essence in Phenomenological Psychiatry and Psychopathology. Thaumàzein -
.
Riv Filos
. Forthcoming.0035-6239
27.
Jaspers
K
.
General Psychopathology
.
Baltimore
:
The Johns Hopkins University Press
;
1997
.
28.
Messas
GP
.
Psicopatologia e transformação: um esboço fenômeno-estrutural
. 1st ed.
São Paulo
:
Casa do Psicólogo
;
2004
.
29.
Blankenburg
W
.
Wie weit reicht die dialektische Betrachtungsweise in der Psychiatrie?
[What are the limits of dialectic approach in psychiatry?]
.
Z Klin Psychol Psychother
.
1981
Jan
;
29
(
1
):
45
66
.
[PubMed]
0300-869X
30.
Blankenburg
W
. A dialectical conception of anthropological proportions. In:
De Koonig
A
,
Jenner
F
, editors
.
Phenomenology and Psychiatry
.
London, Toronto, Sydney
:
Academic Press
;
1982
. pp.
35
50
.
31.
Messas
GP
.
Psicose e embriaguez – psicopatologia fenomenológica da temporalidade
. 1st ed.
São Paulo
:
Editora Intermeios
;
2014
b.
32.
Minkowski
E
:
Le temps vécu.
Études Phénoménologiques et Psychopathologiques. Paris, Presses Universitaires de France (PUF),
1995
.
33.
Sass
L
,
Pienkos
E
.
Space, Time, and Atmosphere A Comparative Phenomenology of Melancholia, Mania, and Schizophrenia, Part II
.
J Conscious Stud
.
2013
;
20
:
131
52
.1355-8250
34.
Kemp
R
.
Addiction as temporal disruption: interoception, self, meaning
.
Phenomenol Cogn Sci
.
2018
;
•••
:
1
15
. 1568-7759
35.
Lai
HM
,
Cleary
M
,
Sitharthan
T
,
Hunt
GE
.
Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990-2014: A systematic review and meta-analysis
.
Drug Alcohol Depend
.
2015
Sep
;
154
:
1
13
.
[PubMed]
0376-8716
36.
Tolliver
BK
,
Anton
RF
.
Assessment and treatment of mood disorders in the context of substance abuse
.
Dialogues Clin Neurosci
.
2015
Jun
;
17
(
2
):
181
90
.
[PubMed]
1958-5969
37.
Cooper
ML
: Does Drinking Promote Risky Sexual Behavior?: A Complex Answer to a Simple Question.
2006
;15:19-23.
38.
WHO
. [World Health Organization]: Interpersonal violence and illicit drugs. Liverpool,
2009
. In: http://www.who.int/violenceprevention/interpersonal_violence_and_illicit_drug_use.pdf
39.
WHO
. [World Health Organization]: Drug use and road safety: a policy brief. Geneva, Switzerland,
2016
. In: http://www.who.int/violence_injury_prevention/publications/road_traffic/Drug_use_and_road_safety.pdf
40.
Zubaran
C
,
Foresti
K
,
Thorell
MR
,
Franceschini
P
,
Homero
W
.
Depressive symptoms in crack and inhalant users in Southern Brazil
.
J Ethn Subst Abuse
.
2010
;
9
(
3
):
221
36
.
[PubMed]
1533-2640
41.
Penberthy
JK
,
Gioia
CJ
,
Konig
A
,
Martin
AM
,
Cockrell
SA
.
Co-Occurring Chronic Depression and Alcohol Dependence: A Novel Treatment Approach
.
Addict Disord Their Treat
.
2013
;
•••
:
1
20
.1531-5754
42.
Zutt
J
.
Zur Anthropologie der Sucht
.
Nervenarzt
.
1958
Oct
;
29
(
10
):
439
45
.
[PubMed]
0028-2804
43.
Moskalewicz
M
.
Three modes of distorted temporal experience in addiction: daily life, drug ecstasy and recovery-a phenomenological perspective
.
Archive of the History of Philosophy and Social Thought
.
2016
;
61
:
197
212
.
44.
Nutt
DJ
.
The role of the opioid system in alcohol dependence
.
J Psychopharmacol
.
2014
Jan
;
28
(
1
):
8
22
.
[PubMed]
0269-8811
45.
Maisel
NC
,
Blodgett
JC
,
Wilbourne
PL
,
Humphreys
K
,
Finney
JW
.
Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?
Addiction
.
2013
Feb
;
108
(
2
):
275
93
.
[PubMed]
0965-2140
46.
Plunk
AD
,
Syed-Mohammed
H
,
Cavazos-Rehg
P
,
Bierut
LJ
,
Grucza
RA
:
Alcohol consumption, heavy drinking, and mortality: rethinking the j-shaped curve.
Alcohol Clin Exp Res
2014
;38:471-478.8. doi: .
47.
Schoenborn
CA
,
Stommel
M
,
Ward
BW
.
Mortality risks associated with average drinking level and episodic heavy drinking
.
Subst Use Misuse
.
2014
Aug
;
49
(
10
):
1250
8
.
[PubMed]
1082-6084
48.
Verheul
R
.
Co-morbidity of personality disorders in individuals with substance use disorders
.
Eur Psychiatry
.
2001
Aug
;
16
(
5
):
274
82
.
[PubMed]
0924-9338
49.
Foulds
JA
,
Boden
JM
,
Newton-Howes
GM
,
Mulder
RT
,
Horwood
LJ
.
The role of novelty seeking as a predictor of substance use disorder outcomes in early adulthood
.
Addiction
.
2017
Sep
;
112
(
9
):
1629
37
.
[PubMed]
0965-2140
50.
Soldani
J
.
Ce que les régimes de temporalités peuvent nous apprendre sur les sports.
Temporalités [En ligne]
2017
;25. In: https://journals.openedition.org/temporalites/3610
51.
van Herdeen
A
.
The restructuring of temporality during art making
.
South African Journal of Art History
.
2016
;
31
:
187
204
.
52.
Klostermann
K
,
O’Farrell
TJ
.
Treating substance abuse: partner and family approaches
.
Soc Work Public Health
.
2013
;
28
(
3-4
):
234
47
.
[PubMed]
1937-1918
53.
Kumpfer
KL
,
Alvarado
R
,
Whiteside
HO
.
Family-based interventions for substance use and misuse prevention
.
Subst Use Misuse
.
2003
Sep-Nov
;
38
(
11-13
):
1759
87
.
[PubMed]
1082-6084
54.
Kemp
R
,
Butler
A
.
Love, Hate and Emergence of Self in Addiction
.
Existential Anal
.
2014
;
25
:
257
68
.0958-0476
55.
Lander
L
,
Howsare
J
,
Byrne
M
.
The impact of substance use disorders on families and children: from theory to practice
.
Soc Work Public Health
.
2013
;
28
(
3-4
):
194
205
.
[PubMed]
1937-1918
56.
Kellogg
S
.
Identity and recovery
.
Psychotherapy
.
1993
;
30
(
2
):
235
44
. 0033-3204
57.
Chappel
JN
,
DuPont
RL
.
Twelve-step and mutual-help programs for addictive disorders
.
Psychiatr Clin North Am
.
1999
Jun
;
22
(
2
):
425
46
.
[PubMed]
0193-953X
58.
Souza
J
:
Crack e exclusão social.
Brasília, Ministério da Justiça e Cidadania, Secretaria Nacional de Política sobre Drogas,
2016
.
59.
Brache
K
.
Advancing interpersonal therapy for substance use disorders
.
Am J Drug Alcohol Abuse
.
2012
Jul
;
38
(
4
):
293
8
.
[PubMed]
0095-2990
60.
SAMHSA [Substance Abuse and Mental Health Services Administration]: Brief Humanistic and Existential Therapies; Brief Interventions and Brief Therapies for Substance Abuse. Center for Substance Abuse Treatment, Rockville, MD,
1999
, vol 34.
61.
Kimura
B
.
Patologia dell’immediatezza
.
Scritti di Psicoptologia Fenomenológica, Giovanni Fioretti Editore
;
2005
. pp.
81
109
.
62.
Boles
SM
,
Miotto
K
.
Substance abuse and violence: A review of the literature
.
Aggress Violent Behav
.
2003
Mar
;
8
(
2
):
155
74
. 1359-1789
63.
Boulter
CE
.
Searching for wholeness in a fragmented world: a consideration of relational factors to self, others and beyond.
Doctoral thesis, Department of Psychology, School of Arts & Social Sciences, City University of London,
2018
.
64.
Fals-Stewart
W
,
Golden
J
,
Schumacher
JA
.
Intimate partner violence and substance use: a longitudinal day-to-day examination
.
Addict Behav
.
2003
Dec
;
28
(
9
):
1555
74
.
[PubMed]
0306-4603
65.
Callinan
S
,
Laslett
AM
,
Rekve
D
,
Room
R
,
Waleewong
O
,
Benegal
V
, et al
Alcohol’s harm to others: an international collaborative project
.
Int J Alcohol Drug Res
.
2016
;
5
(
2
):
25
32
. 1925-7066
66.
Schlimme
JE
.
Addiction and self-determination: a phenomenological approach
.
Theor Med Bioeth
.
2010
Feb
;
31
(
1
):
49
62
.
[PubMed]
1386-7415
67.
Sadler
JZ
.
Values and psychiatric diagnosis
.
Oxford, New York
:
Oxford University Press
;
2005
.
68.
Fulford
K
. Values-based practice: a new partner to evidence-based practice and a first for psychiatry? In:
Singh
A
,
Singh
S
, editors
.
Medicine, mental health, science, religion, and well-being, Mens Sana Monographs
.
MSM
;
2008
. pp.
10
21
.
69.
Fulford
K
,
Stanghellini
G
. Values and values-based practice. In:
Stanghellini
G
,
Broome
M
,
Fernandez
A
,
Fusar Poli
P
,
Raballo
A
,
Rosfort
R
, editors
.
Handbook of phenomenological psychopathology
.
Oxford
:
Oxford University Press
;
2018
.
70.
Fry
CL
,
Khoshnood
K
,
Power
R
,
Sharma
M
.
Harm reduction ethics: acknowledging the values and beliefs behind our actions
.
Int J Drug Policy
.
2008
Feb
;
19
(
1
):
1
3
.
[PubMed]
0955-3959
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.